{"nct_id":"NCT01647971","title":"Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma","status":"COMPLETED","status_verified_date":"2022-11","start_date":"2012-07-19","start_date_type":"ACTUAL","primary_completion_date":"2015-05","primary_completion_date_type":"ACTUAL","completion_date":"2015-05","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TGTX"]}